- 1. (+-)-N,alpha-Dimethylcyclohexaneethylamine
- [A propylamine derivative with sympathomimetic property. Propylhexedrine binds to and activates alpha-adrenergic receptors in the mucosa of the respiratory tract, thereby mimicking the actions of norepinephrine and epinephrine. This results in vasoconstriction and reduces swelling and inflammation of the mucous membrane lining, therefore relieving nasal and sinus congestion. ( NCI )] (UMLS (NCI) C0033508) =Organic Chemical; Pharmacologic Substance ;
| - 51. NADPH dehydrogenase
- [A flavoprotein that reversibly oxidizes NADPH to NADP and a reduced acceptor. EC 1.6.99.1. ( MSH )] (UMLS (CSP) C0027312) =Amino Acid, Peptide, or Protein; Enzyme
|
- 2. (-)-Naloxone
- [specific opiate antagonist with no agonist activity, a competitive antagonist at mu, delta, and kappa opioid receptors. ( CSP )] (UMLS (NCI) C0027358) =Organic Chemical; Pharmacologic Substance ;
=morphinan;
MORPHINE;
Narcotic Antagonist;
[CN102] OPIOID ANTAGONIST ANALGESICS =NALTREXONE;
NALOXONE HYDROCHLORIDE;
| - 52. NADPH Dependent Diflavin Oxidoreductase 1
- [Broadly expressed by human NR1 Gene (FNR Family), 597-aa 67-kDa cytoplasmic NADPH-Dependent FMN and FAD Containing Oxidoreductase is an enzyme homologous to cytochrome P-450 reductase that binds FMN, FAD, and NADPH cofactors, reduces cytochrome c, and metabolizes electron acceptors doxorubicin, menadione, and potassium ferricyanide. NR1 shares 41 to 44% similarity with nitric oxide synthase-2, methionine synthase transferase, and P-450 reductase. It may play a role in metabolic activation of bioreductive anticancer drugs and other chemicals activated by 1-electron reduction. (NCI) ( NCI )] (UMLS (NCI) C1312754) NADPH-Dependent FMN and FAD Containing Oxidoreductase;
NDOR1;
NR1 =Amino Acid, Peptide, or Protein; Enzyme ;
|
- 3. 1,8-Naphthyridine-3-carboxylic Acid, 1-ethyl-1,4-dihydro-7-methyl-4-oxo-
- [A synthetic quinolone and antibacterial agent with urinary tract antiseptic activity. Nalidixic acid concentrates in the renal tubules and bladder and exerts its local antibacterial actions by interference of DNA gyrase activity, thereby inhibiting DNA synthesis during bacterial replication in a dose-dependent manner. Nalidixic acid is active against most gram-negative organisms that cause urinary tract infections. ( NCI )] (UMLS (NCI) C0027353) =Organic Chemical; Pharmacologic Substance =Naphthyridines;
[AM900] ANTI-INFECTIVES, OTHER =Nalidixate 250 MG;
Nalidixate 500 MG;
NALIDIXIC ACID 1 GM;
NALIDIXIC ACID 250 MG/5ML;
| - 53. NADPH oxidase
- [A flavoprotein enzyme that catalyzes the univalent reduction of OXYGEN using NADPH as an electron donor to create SUPEROXIDE ANION. The enzyme is dependent on a variety of CYTOCHROMES. Defects in the production of superoxide ions by enzymes such as NADPH oxidase result in GRANULOMATOUS DISEASE, CHRONIC. ( MSH )] (UMLS (CSP) C0068355) =Amino Acid, Peptide, or Protein; Enzyme ;
|
- 4. 1-Naphthacenecarboxylic acid, 4-[[O-2,6-dideoxy-.alpha.-L-lyxo-hexopyranosyl-(1.fwdarw.4)-O-2, 6-dideoxy-.alpha.-L-lyxo-hexopyranosyl-(1.fwdarw.4)-2,3, 6-trideoxy-3-(dimethylamino)-.alpha.-L-lyxo-hexopyranosyl]oxy]-2-e thyl-1,2,3,4,6,11-hexahydro-2,5,7,10
- [An antineoplastic oligosaccharide anthracycline antineoplastic antibiotic isolated from the bacterium Actinosporangium bohemicum. Marcellomycin intercalates into DNA and induces DNA crosslinks, thereby inhibiting DNA replication and repair and RNA and protein synthesis. This agent also induces differentiation in HL-60 promyelocytic leukemia cells by interfering with glycoprotein synthesis. (NCI04) ( NCI )] (UMLS (NCI) C0065718) =Organic Chemical; Antibiotic
| - 54. Nadroparin
- [A low molecular weight heparin (LMWH) composed of a heterogeneous mixture of sulfated polysaccharide glycosaminoglycan chains obtained by depolymerisation of porcine mucosal sodium heparin, extraction/purification and conversion to the calcium salt. Nadroparin binds to antithrombin III (ATIII) and inhibits the activity of activated factor X (factor Xa), thereby inhibiting the final common pathway of the coagulation cascade and preventing the formation of a cross-linked fibrin clot. ( NCI )] (UMLS (NCI) C0206232) =Carbohydrate; Pharmacologic Substance
|
- 5. 1-Naphthalenemethanamine, a-methyl-N-(3-(3-(trifluoromethyl)phenyl)propyl)-,(aR)-, Hydrochloride
- [An oral calcimimetic. Cinacalcet hydrochloride increases the sensitivity of the calcium-sensing receptors on the chief cells in the parathyroid gland to extracellular calcium, thereby reducing parathyroid hormone secretion. A reduction in parathyroid hormone levels inhibits osteoclast activity, favourably impacts bone-specific alkaline phosphatase, bone turnover, and bone fibrosis, and leads to normalization of serum calcium and phosphate levels. Cinacalcet hydrochloride is a treatment option for primary and secondary hyperparathyroidism and parathyroid carcinoma. ( NCI )] (UMLS (NCI) C1260199) CINACALCET HCL UNIDENTIFIED;
CINACALCET HCL UNIDENTIFIED;
CINACALCET HYDROCHLORIDE;
=Organic Chemical; Pharmacologic Substance ;
| - 55. Naegleria
- [free living soil amoeba pathogenic to humans and animals; occurs also in water and sewage; most commonly found species in man is Naegleri fowleri which is the pathogen for primary amebic meningoencephalitis in primates. ( CSP )] (UMLS (CSP) C0027320) =Invertebrate ;
=Sarcodina;
|
- 6. 2-Naphthacenecarboxamide, 4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methylene-1,11-dioxo-, Monohydrochloride,(4S-(4alpha,4aalpha,5alpha,5aalpha,12aalpha))-
- [The hydrochloride salt form of methacycline, a tetracycline antibiotic with broad-spectrum antibacterial and antiprotozoal activity. Methacycline hydrochloride is bacteriostatic and inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, thereby preventing the addition of amino acids to the growing peptide chain. This tetracycline is active against a wide range of gram-positive and gram-negative bacteria. ( NCI )] (UMLS (NCI) C0770655) Methacycline Hydrochloride;
METHACYCLINE HYDROCHLORIDE PREPARATION;
Optimycin;
Rindex =Organic Chemical; Antibiotic =METHACYCLINE;
=METHACYCLINE HYDROCHLORIDE 300 MG;
METHACYCLINE HYDROCHLORIDE 150 MG | - 56. Nafcil
- (UMLS (NCI) C0733814) =Organic Chemical; Antibiotic ;
|
- 7. 2-Naphthacenecarboxamide, 7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, Monohydrochloride(4S-(4alpha,4aalpha,5aalpha,6beta,12aalpha))-
- [A tetracycline with broad-spectrum antibacterial and antiprotozoal activity. Chlortetracycline hydrochloride is bacteriostatic and inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, thereby preventing the addition of amino acids to the growing peptide chain. This tetracycline is active against a wide range of gram-positive and gram-negative organisms, spirochetes, rickettsial species, certain protozoa and Mycoplasma and Chlamydia organisms. ( NCI )] (UMLS (NCI) C0085855) =Organic Chemical; Antibiotic =chlortetracycline;
| - 57. NAFCILLIN
- [A semi-synthetic naphthalene and beta-lactam antibiotic with antibacterial activity. Nafcillin inhibits bacterial wall synthesis by a mechanism of action similar to penicillin. Penicillinase-resistant Nafcillin is used to treat infections caused by penicillin-resistant strains of Staphylococci. (NCI04) ( NCI )] (UMLS (NCI) C0027324) =Organic Chemical; Antibiotic =Penicillanic Acid;
[AM053] PENICILLINASE-RESISTANT PENICILLINS =NAFCILLIN SODIUM;
NAFCILLIN SODIUM MONOHYDRATE;
NAFCILLIN SODIUM;
NAFCILLIN SODIUM MONOHYDRATE;
|
- 8. 2-Naphthoic Acid, 4,4'-methylenebis(3-hydroxy-, ester with 2-(2-(4-(p-chloro-alpha-phenylbenzyl)-1-piperazinyl)-ethoxy)ethanol
- [The pamoate salt form of hydroxyzine, a synthetic piperazine histamine H1-receptor antagonist with anti-allergic, antispasmodic, sedative, anti-emetic and anti-anxiety properties. Hydroxyzine pamoate blocks the H1 histamine receptor and prevents the symptoms that are caused by histamine activity on capillaries, bronchial smooth muscle, and gastrointestinal smooth muscle, including vasodilatation, increased capillary permeability, bronchoconstriction, and spasmodic contraction of gastrointestinal smooth muscle. In addition, hydroxyzine pamoate crosses the blood-brain barrier and acts on the histamine H1-receptors in the central nervous system. (NCI05) ( NCI )] (UMLS (NCI) C0700539) =Organic Chemical; Pharmacologic Substance =HYDROXYZINE;
=HYDROXYZINE PAMOATE 100 MG;
HYDROXYZINE PAMOATE 50 MG;
HYDROXYZINE PAMOATE 25 MG/5ML;
HYDROXYZINE PAMOATE 25 MG;
| - 58. Nafoxidine
- [A triphenylethylene nonsteroidal agent that acts as a partial estrogen antagonist. Nafoxidine competes with endogenous estrogen for binding to specific estrogen receptors. This agent also inhibits angiogenesis in some tissues by blocking the effects of fibroblast growth factor (FGF) and vascular endothelial growth factor (VEGF); paradoxically, it may enhance angiogenesis in uterine tissue. Nafoxidine also induces oxidative stress, protein kinase C and calcium signaling. (NCI04) ( NCI )] (UMLS (NCI) C0027328) =Organic Chemical; Pharmacologic Substance
|
- 9. 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8, 9,10-tetrahydro-6,8,11-trihydroxy-8-(1-hydroxyethyl)-1-methoxy-, (8S-cis)-, hydrochloride
- (UMLS (NCI) C0969848) Daunomycinol HCl;
Duborimycin Hydrochloride;
Duborimycine, Hydrochloride;
=Organic Chemical; Pharmacologic Substance ;
| - 59. NAG
- [This gene may play a role in the development of neuroblastoma. ( NCI )] (UMLS (NCI) C1334861) NAG Gene;
Neuroblastoma-Amplified Protein Gene;
=Gene or Genome ;
|
- 10. 5,12-Naphthacenedione, 7, 8, 9, 10-tetrahydro-6, 8, 11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-10-[[2, 3, 6-trideoxy-3-(4-morpholinyl)-.alpha.-L-lyxo-hexopyranosyl] oxy]-, hydrochloride, (8S-cis)-
- [A semisynthetic derivative of the anthracycline antineoplastic antibiotic doxorubicin. As an antineoplastic agent, morpholinodoxorubicin is more potent than doxorubicin. Similar to doxorubicin, morpholinodoxorubicin intercalates into DNA and causes single- and double-strand breaks in DNA via inhibition of topoisomerase I and II. Unlike doxorubicin, this agent is metabolized in vivo to a DNA-alkylating derivative that forms DNA interstrand cross-links, thereby potentiating its doxorubicin-like cytotoxicity. (NCI04) ( NCI )] (UMLS (NCI) C0173377) =Organic Chemical; Pharmacologic Substance
| - 60. nagana
- [ ] (UMLS (CSP) C0027333) =Disease or Syndrome ;
|
- 11. 5,12-Naphthacenedione, 8-acetyl-10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S-cis)-, hydrochloride
- [The hydrochloride salt of an anthracycline antineoplastic antibiotic with therapeutic effects similar to those of doxorubicin. Daunorubicin exhibits cytotoxic activity through topoisomerase-mediated interaction with DNA, thereby inhibiting DNA replication and repair and RNA and protein synthesis. ( NCI )] (UMLS (NCI) C0282123) =Organic Chemical; Pharmacologic Substance ;
=(8S-cis)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione;
=DAUNORUBICIN HYDROCHLORIDE 20 MG | - 61. Naganin
- (UMLS (NCI) C0878166) =Organic Chemical; Pharmacologic Substance
|
- 12. N acetyl glutamate synthetase deficiency
- [ ] (UMLS (CSP) C0268543) =Disease or Syndrome
| - 62. Naganol
- (UMLS (NCI) C0878165) =Organic Chemical; Pharmacologic Substance
|
- 13. N acetyl glutamate synthethase deficiency
- [ ] (UMLS (CSP) C0598385) =Pathologic Function
| - 63. nagarse
- [ ] (UMLS (CSP) C0038599) =Amino Acid, Peptide, or Protein; Enzyme
|
- 14. N acetyl L glutamate
- [ ] (UMLS (CSP) C0067724) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 64. nagarse proteinase
- [ ] (UMLS (CSP) C0599498) =Amino Acid, Peptide, or Protein; Enzyme
|
- 15. N acetylgalactosamine
- [N-acetyl derivative of galactosamine. ( CSP )] (UMLS (CSP) C0001055) =Carbohydrate; Biologically Active Substance ;
| - 65. nail
- [The thin, horny plates that cover the dorsal surfaces of the distal phalanges of the fingers and toes of primates. ( MSH )] (UMLS (CSP) C0027342) =Body Part, Organ, or Organ Component ;
=Body Part;
|
- 16. N acetylglucosamine
- [N-acetyl derivative of glucosamine. ( CSP )] (UMLS (CSP) C0001056) =Carbohydrate; Biologically Active Substance ;
| - 66. Nail
- (UMLS (HL7) C0444077) =Body Substance ;
=SpecimenEntityType;
◊ (UMLS (HL7) C1546715) Intellectual Product Specimen Source Codes; |
- 17. N acetylglucosaminidase
- [ ] (UMLS (CSP) C0699917) =Amino Acid, Peptide, or Protein; Enzyme =O glycosidase;
| - 67. NAIL ANOMALIES NEC
- [ ] (UMLS (ICD9CM) C0432351) =Congenital Abnormality
|
- 18. N acetylhexosamine
- [ ] (UMLS (CSP) C0597000) =Carbohydrate
| - 68. Nail Bed
- (UMLS (HL7) C0221997) =Body Part, Organ, or Organ Component =Body Part;
|
- 19. N acetylneuraminate
- [N-acetyl derivative of the amino sugar neuraminic acid; the most common of the sialic acids; occurs in many polysaccharides, glycoproteins, and glycolipids in animals and bacteria. ( CSP )] (UMLS (CSP) C0178446) =Carbohydrate ;
=sialate;
| - 69. Nail changes
- (UMLS (NCI) C0234909) =Finding
|
- 20. N acylaminoacid
- [ ] (UMLS (CSP) C0597001) =Amino Acid, Peptide, or Protein =aa;
| - 70. nail patella syndrome
- [A syndrome of multiple abnormalities characterized by the absence or hypoplasia of the PATELLA and congenital nail dystrophy. It is a genetically determined autosomal dominant trait. ( MSH )] (UMLS (CSP) C0027341) =Congenital Abnormality; Disease or Syndrome =Abnormalities, Multiple;
DISEASE OF NAIL NOS |
- 21. N acylation
- [ ] (UMLS (CSP) C0597002) =Phenomenon or Process =acylation;
| - 71. NAIL REMOVAL
- [ ] (UMLS (ICD9CM) C0177698) =Therapeutic or Preventive Procedure
|
- 22. N alkylaminoacid
- [ ] (UMLS (CSP) C0597003) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Biologically Active Substance
| - 72. Nail, Toe
- (UMLS (HL7) C0222007) =Body Part, Organ, or Organ Component =Body Part;
|
- 23. N-Acetyltransferase 2 (Arylamine N-Acetyltransferase) Gene
- [This gene plays a role in both the activation and deactivation of xenobiotics. ( NCI )] (UMLS (NCI) C0796518) NAT2;
NAT2 Gene;
=Gene or Genome | - 73. NailRoute
- [Nail ( HL7V3.0 )] (UMLS (HL7) C1700804) =Functional Concept ;
=RouteBySite;
=Topical application, nail;
|
- 24. N-Acetyltyrosine
- (UMLS (NCI) C0067794) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 74. Nairobi sheep disease virus
- [A species of NAIROVIRUS, transmitted by the ixodid ticks and producing a lethal gastroenteritis in sheep and goats. Though a major veterinary pathogen, its effect on humans has not been firmly established. ( MSH )] (UMLS (CSP) C0027346) =Virus ;
|
- 25. NA
- [A country in Southern Africa, bordering the South Atlantic Ocean, between Angola and South Africa. (NCI) ( NCI )] (UMLS (NCI) C0027366) =Geographic Area
| - 75. Nairovirus
- [A genus of the family BUNYAVIRIDAE named after NAIROBI SHEEP DISEASE, an acute, hemorrhagic, tick-borne, gastroenteritis affecting sheep and goats. The type species is Dugbe virus. Some viruses in this genus are capable of causing severe and fatal disease in humans. ( MSH )] (UMLS (CSP) C0085381) =Virus
|
- 26. NA
- [A measurement of the sodium in a biological specimen. ( NCI )] (UMLS (NCI) C0337443) =Laboratory Procedure
| - 76. NAK
- [Encoded by human TBK1 Gene, 729-aa 84-kDa TANK-Binding Kinase 1 (similar to IKB kinases) mediates NFKB activation in response to certain growth factors. TBK1 forms a complex with TRAF2 and TANK IKB protein to release NFKB inhibition by TANK. NFKB complex is inhibited by IKB proteins, which trap it in the cytoplasm. IKB serine phosphorylation by IKB kinases marks them for ubiquitinated destruction, allowing NFKB activation and nuclear translocation. (NCI) ( NCI )] (UMLS (NCI) C0911531) NF-KB-Activating Kinase;
NF-KB-Activating Kinase NAK;
T2K;
TANK Binding Kinase TBK1;
TANK-Binding Kinase 1;
TBK1 =Amino Acid, Peptide, or Protein; Enzyme |
- 27. Na+ element
- [chief cation of the extracellular body fluids. ( CSP )] (UMLS (CSP) C0597484) =Pharmacologic Substance =ion;
| - 77. Naknek Native Village
- (UMLS (HL7) C1550923) =Population Group =NativeEntityAlaska;
|
- 28. Na/H exchanger
- [plasma membrane exchange glycoprotein transporters that function in intracellular pH regulation, cell volume regulation and cellular response to many different hormones and mitogens. ( CSP )] (UMLS (CSP) C0074785) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
=membrane transport protein;
| - 78. Nakoda
- (UMLS (HL7) C1551961) Nakota;
Nakota Sioux =Language =Dakotan;
|
- 29. NA17-A
- [A specific melanoma antigen protein derived from a patient (NA17) with cutaneous melanoma metastases. The NA17-A antigen is part of the enzyme N-acetyl glucosaminyl-transferase V (GnT-V). Approximately half of melanomas have been found to express significant levels of this atypical protein, which is not expressed by normal tissues. When administered in a vaccine formulation, NA17-A antigen may stimulate a cytotoxic T lymphocyte (CTL) response against tumors that express this antigen, which may result in a reduction in tumor size. ( NCI )] (UMLS (NCI) C1134655) NA17-A Antigen =Pharmacologic Substance; Immunologic Factor ;
| - 79. NALBUPHINE
- [A narcotic used as a pain medication. It appears to be an agonist at kappa opioid receptors and an antagonist or partial agonist at mu opioid receptors. ( MSH )] (UMLS (NCI) C0027348) =Organic Chemical; Pharmacologic Substance =[CN101] OPIOID ANALGESICS;
morphinan =(5alpha,6alpha)-17-(Cyclobutylmethyl)-4,5-epoxymorphinan-3,6,14-triol Hydrochloride |
- 30. Na24 isotope
- [ ] (UMLS (CSP) C0303512) =Element, Ion, or Isotope
| - 80. Nalmefene
- (UMLS (NCI) C0068377) =Organic Chemical; Pharmacologic Substance ;
=NALTREXONE;
[CN102] OPIOID ANTAGONIST ANALGESICS =Morphinan-3,14-diol, 17-(cyclopropylmethyl)-4,5-epoxy-6-methylene-, Hydrochloride,(5alpha)- |
- 31. NAACCR
- [NAACCR Cancer Registry ( HL7V3.0 )] (UMLS (HL7) C1553865) =Intellectual Product =CodeSystem;
| - 81. nalorphine
- [narcotic antagonist with some agonist properties; an antagonist at mu opioid receptors and an agonist at kappa opioid receptors. ( CSP )] (UMLS (CSP) C0027355) =Organic Chemical; Pharmacologic Substance ;
=MORPHINE;
Narcotic Antagonist |
- 32. Nabesna
- (UMLS (HL7) C1551908) Upper Tanana;
=Language =Tanana;
| - 82. NALTREXONE
- [synthetic congener of oxymorphone, chemically related to naloxone; a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction and alcohol dependence. ( CSP )] (UMLS (NCI) C0027360) =Organic Chemical; Pharmacologic Substance ;
=morphinan;
(-)-Naloxone;
Narcotic Antagonist;
[CN102] OPIOID ANTAGONIST ANALGESICS =Nalmefene;
(5alpha)-17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one Hydrochloride;
|
- 33. NABI
- (UMLS (HL7) C1546882) =Health Care Related Organization =Manufacturers of Vaccines (code=MVX);
| - 83. naltrindole
- [ ] (UMLS (CSP) C0068389) =Organic Chemical; Pharmacologic Substance ;
|
- 34. NABI (formerly North American Biologicals, Inc.)
- [NABI (formerly North American Biologicals, Inc.) ( HL7V3.0 )] (UMLS (HL7) C1552896) =Health Care Related Organization ;
=VaccineManufacturer;
| - 84. Name
- [For attributes that represent a name by which an instance of the class is known. ( HL7V3.0 )] (UMLS (HL7) C1554107) =Idea or Concept =MDFAttributeType;
|
- 35. NABILONE
- [A synthetic cannabinoid and dibenzopyrane derivative with anti-emetic activity. Although the mechanism of action has not been fully elucidated yet, it has been suggested that nabilone is a highly selective and strong agonist for the cannabinoid receptors CB1 and CB2, both of which are coupled to Gi/o proteins. The CB1 receptors are expressed predominantly in central and peripheral neurons and receptor stimulation has been implicated in the reduction of chemotherapy-induced nausea. ( NCI )] (UMLS (NCI) C0068333) =Organic Chemical; Pharmacologic Substance ;
=[GA700] ANTIEMETICS;
(-)-.DELTA.9-Tetrahydrocannabinol | - 85. Name
- [The words or language units by which a thing is known. ( NCI )] (UMLS (NCI) C0027365) =Intellectual Product
|
- 36. Nabothian Cyst
- (UMLS (NCI) C0027269) =Disease or Syndrome
| - 86. Name assembly order
- (UMLS (HL7) C1547824) =Idea or Concept =HL7 Vocabulary Version 2.5;
=Prefix Family Middle Given Suffix;
Prefix Given Middle Family Suffix |
- 37. NAD analog
- [ ] (UMLS (CSP) C0920599) =Nucleic Acid, Nucleoside, or Nucleotide
| - 87. Name at Birth
- (UMLS (HL7) C1549652) =Idea or Concept =Name type;
|
- 38. NAD kinase
- [ ] (UMLS (CSP) C0068337) =Amino Acid, Peptide, or Protein; Enzyme ;
=alcohol phosphotransferase;
| - 88. Name context
- (UMLS (HL7) C1547828) =Idea or Concept =HL7 Vocabulary Version 2.5;
|
- 39. NAD phosphate
- [nicotinamide adenine dinucleotide phosphate; a coenzyme composed of ribosylnicotinamide 5'-phosphate (NMN) coupled by pyrophosphate linkage to the 5'-phosphate adenosine 2',5'-bisphosphate; serves as an electron carrier in a number of reactions, being alternately oxidized (NADP+) and reduced ( NADPH). ( CSP )] (UMLS (CSP) C0027303) =Nucleic Acid, Nucleoside, or Nucleotide; Biologically Active Substance ;
=adenine nucleotide;
cofactor;
high energy compound;
nicotinamide ribotide | - 89. Name misspelling
- (UMLS (HL7) C1548783) =Qualitative Concept =Specimen Reject Reason;
|
- 40. NAD transhydrogenase
- [An enzyme present in the mitochondrial membrane of animals and in microorganisms. In the presence of energy (ATP) it catalyzes reversibly the reduction of NAD by NADPH to yield NADP and NADH. This reaction permits the utilization of the reducing properties of NADPH by the respiratory chain and in the reverse direction it allows the reduction of NADP for biosynthetic purposes. EC 1.6.1.1. ( MSH )] (UMLS (CSP) C0027307) =Amino Acid, Peptide, or Protein; Enzyme ;
=NAD(P)H oxidoreductase;
| - 90. Name of Partner/Spouse (retained for backward compatibility only)
- (UMLS (HL7) C1549659) =Idea or Concept =Name type;
|
- 41. NAD(+) ADP ribosyltransferase
- [An enzyme that catalyze the transfer of ADP-RIBOSE from NAD+ to an amino acid residue in a specific protein substrate. This reaction is catalyzed by both mono(ADP-ribose) transferases as well as POLY(ADP-RIBOSE) POLYMERASES. When the term NAD+ ADP-Ribosyltransferase refers to EC 2.4.2.30 it is referring to POLY(ADP-RIBOSE) POLYMERASES. ( MSH )] (UMLS (CSP) C1138564) =Amino Acid, Peptide, or Protein; Enzyme
| - 91. Name type
- (UMLS (HL7) C1547610) =Idea or Concept =HL7 Vocabulary Version 2.5;
=Maiden;
Alias Name;
Name at Birth;
Adopted Name;
Licensing Name;
Nickname /_Call me_ Name/Street Name;
Name of Partner/Spouse (retained for backward compatibility only);
Registered Name (animals only);
Coded Pseudo-Name to ensure anonymity;
Indigenous/Tribal/Community Name;
Unspecified;
Display Name;
Legal Name |
- 42. NAD(H) analog
- [synthetic or natural compounds which resemble the coenzyme nicotinamide adenine dinucleotide in structure and/or function. ( CSP )] (UMLS (CSP) C0597009) =Nucleic Acid, Nucleoside, or Nucleotide =nucleotide analog;
| - 92. Name with location and date
- (UMLS (HL7) C1547374) =Idea or Concept =Data type;
|
- 43. NAD(P)H Dehydrogenase, Quinone 1 Gene
- [This gene is involved in drug/xenobiotic metabolism, biosynthetic processes and the prevention of cellular oxidative stress. ( NCI )] (UMLS (NCI) C0919428) NQO1;
NQO1 Gene =Gene or Genome ;
| - 93. Name/address change
- (UMLS (HL7) C1546916) =Idea or Concept =Insurance Company Contact Reason;
|
- 44. NAD(P)H oxidoreductase
- [A group of oxidoreductases that act on NADH or NADPH. In general, enzymes using NADH or NADPH to reduce a substrate are classified according to the reverse reaction, in which NAD+ or NADP+ is formally regarded as an acceptor. This subclass includes only those enzymes in which some other redox carrier is the acceptor. (Enzyme Nomenclature, 1992, p100) EC 1.6. ( MSH )] (UMLS (CSP) C0027298) =Amino Acid, Peptide, or Protein; Enzyme ;
=dehydrogenase;
=glutathione reductase;
NAD transhydrogenase;
nitrate reductase;
cytochrome b5 reductase;
FMN reductase;
NADPH cytochrome c2 reductase;
hydrogen peroxide generating oxidase | - 94. Name/address representation
- (UMLS (HL7) C1547843) =Idea or Concept =HL7 Vocabulary Version 2.5;
=Alphabetic (i.e., Default or some single-byte);
Ideographic (i.e., Kanji);
Phonetic (i.e., ASCII, Katakana, Hiragana, etc.);
|
- 45. NADE
- [Cloned by its ability to interact with the death domain of nerve growth factor receptor. Likely to be involved in nerve growth factor-mediated apoptosis. (from OMIM) ( NCI )] (UMLS (NCI) C1334944) Nerve Growth Factor Receptor Associated Protein 1;
Nerve Growth Factor Receptor-Associated Cell Death Executor;
NGFRAP1;
Ovarian Granulosa Cell Protein (13kD);
p75(NTR)-Associated Cell Death Executor =Amino Acid, Peptide, or Protein; Biologically Active Substance | - 95. named group
- [tree section heading term for specific named groups; do not index. ( CSP )] (UMLS (CSP) C0597010) =Population Group =CRISP Thesaurus;
=ethnic group;
Area;
disabled;
migrant;
Job;
veteran;
homeless;
immigrant;
age group;
religious group;
tag term;
medically disadvantaged population |
- 46. Nadene
- (UMLS (HL7) C1699250) =Language =AmericanIndianAlaskaNativeLanguages;
=Thlinget;
AthapaskanEyak | - 96. Namenda
- (UMLS (NCI) C1330412) =Organic Chemical; Pharmacologic Substance
|
- 47. NADH analog
- [ ] (UMLS (CSP) C0920600) =Nucleic Acid, Nucleoside, or Nucleotide
| - 97. NameRepresentationUse
- [Identifies the different representations of a name. The representation may affect how the name is used. (E.g. use of Ideographic for formal communications.) ( HL7V3.0 )] (UMLS (HL7) C1699383) =Classification ;
=OrganizationNameUse;
PersonNameUse =Alphabetic;
Syllabic;
Ideographic |
- 48. NADH oxidoreductase
- [ ] (UMLS (CSP) C0682753) =Amino Acid, Peptide, or Protein; Enzyme
| - 98. Namespace ID
- (UMLS (HL7) C1547700) =Intellectual Product ;
=HL7 Vocabulary Version 2.5;
|
- 49. NADOLOL
- [A non-selective beta-adrenergic antagonist with antihypertensive and antiarrhythmic activities. Nadolol competitively blocks beta-1 adrenergic receptors located in the heart and vascular smooth muscle, therefore inhibiting the effects of catecholamines, epinephrine, and norepinephrine. As a result, this agent produces negative inotropic and chronotropic effects. Nadolol exerts its antiarrhythmic effect via impairment of atrioventricular (AV) node conduction and reduction of sinus rate. In addition, nadolol blocks beta-2 adrenergic receptors located in the bronchiole smooth muscle resulting in vasoconstriction. Furthermore, beta-2 receptor blockage within the juxtaglomerular apparatus leads to the inhibition of renin production, as well as subsequent reduction in angiotensin II and aldosterone levels, thereby inhibiting angiotensin II and aldosterone dependent vasoconstriction and water retention. ( NCI )] (UMLS (NCI) C0027302) =Organic Chemical; Pharmacologic Substance ;
=Propanolamines;
[CV100] BETA-BLOCKERS/RELATED =NADOLOL 120 MG;
NADOLOL 20 MG;
NADOLOL 40 MG;
NADOLOL 80 MG;
NADOLOL 160 MG | - 99. NANDA
- [North American Nursing Diagnosis Association, Philadelphia, PA. ( HL7V3.0 )] (UMLS (HL7) C1140111) =Intellectual Product =Code;
CodeSystem |
- 50. NADPH cytochrome c2 reductase
- [ ] (UMLS (CSP) C0311682) =Amino Acid, Peptide, or Protein; Enzyme =NAD(P)H oxidoreductase;
| - 100. NANDROLONE DECANOATE
- [The decanoate salt form of nandrolone, an anabolic steroid analog of testosterone with androgenic, anabolic, and erythropoietin stimulating effects. Nandrolone enters the cell and binds to and activates specific nuclear androgen receptors in responsive tissue, including the prostate, seminal vesicles, scrotum, penis, larynx, hair follicles, muscle, and bone. The resulting activated hormone receptor complex translocates into the nucleus and binds to androgen response elements (ARE) in the promoter region of targeted genes, where the complex promotes gene expression necessary for maintaining male sex characteristics. Mimicking the negative feedback mechanism of testosterone, nandrolone decanoate also suppresses the secretion of luteinizing hormone (LH). Furthermore, this agent also stimulates erythropoietin production by enhancing the production of erythropoietic stimulating factors. ( NCI )] (UMLS (NCI) C0068395) =Steroid; Pharmacologic Substance; Hormone =19 nortestosterone;
=NANDROLONE DECANOATE 50 MG/ML;
NANDROLONE DECANOATE 100 MG/ML;
NANDROLONE DECANOATE 200 MG/ML |
home
